Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.

Yunxia Z, Jun C, Guanshan Z, Yachao L, Xueke Z, Jin L.

BMC Med Genet. 2010 Feb 26;11:34. doi: 10.1186/1471-2350-11-34. Erratum in: BMC Med Genet. 2010;11:95.

2.

Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients.

Shen H, Yuan Y, Hu HG, Zhong X, Ye XX, Li MD, Fang WJ, Zheng S.

World J Gastroenterol. 2011 Feb 14;17(6):809-16. doi: 10.3748/wjg.v17.i6.809.

3.

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, Fujisawa T, Feng Z, Roth JA, Herz J, Minna JD, Gazdar AF.

J Natl Cancer Inst. 2005 Mar 2;97(5):339-46.

PMID:
15741570
4.

Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.

Chang MH, Lee IK, Si Y, Lee KS, Woo IS, Byun JH.

Cancer Chemother Pharmacol. 2011 Aug;68(2):317-23. doi: 10.1007/s00280-010-1496-5. Epub 2010 Oct 24.

PMID:
20972872
5.

[Study on point mutations of K-ras gene in non-small cell lung cancer in Guangxi].

Zhong W, Chen M, Xian L, Li M.

Zhongguo Fei Ai Za Zhi. 2011 Jun;14(6):507-11. doi: 10.3779/j.issn.1009-3419.2011.06.06. Chinese.

6.

The differentially mutational spectra of the APC, K-ras, and p53 genes in sporadic colorectal cancers from Taiwanese patients.

Wang JY, Hsieh JS, Lu CY, Yu FJ, Wu JY, Chen FM, Huang CJ, Lin SR.

Hepatogastroenterology. 2007 Dec;54(80):2259-65.

PMID:
18265644
7.

Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome.

Wang YC, Lee HS, Chen SK, Yang SC, Chen CY.

J Cancer Res Clin Oncol. 1998;124(9):517-22.

PMID:
9808427
8.
9.

APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.

Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY.

Am Surg. 2005 Apr;71(4):336-43.

PMID:
15943410
10.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR.

N Engl J Med. 2008 Oct 23;359(17):1757-65. doi: 10.1056/NEJMoa0804385.

11.

Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients.

Jeon CH, Lee HI, Shin IH, Park JW.

Int J Colorectal Dis. 2008 Jan;23(1):29-35. Epub 2007 Aug 18.

PMID:
17704924
12.

Rapid detection of low-abundance K-ras mutation in stools of colorectal cancer patients using chip-based temperature gradient capillary electrophoresis.

Zhang H, Wang X, Ma Q, Zhou Z, Fang J.

Lab Invest. 2011 May;91(5):788-98. doi: 10.1038/labinvest.2010.200. Epub 2011 Jan 17.

13.

K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer.

Chen H, Tu H, Meng ZQ, Chen Z, Wang P, Liu LM.

Eur J Surg Oncol. 2010 Jul;36(7):657-62. doi: 10.1016/j.ejso.2010.05.014. Epub 2010 Jun 9.

PMID:
20542658
14.

Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab.

Lurje G, Nagashima F, Zhang W, Yang D, Chang HM, Gordon MA, El-Khoueiry A, Husain H, Wilson PM, Ladner RD, Mauro DJ, Langer C, Rowinsky EK, Lenz HJ.

Clin Cancer Res. 2008 Dec 1;14(23):7884-95. doi: 10.1158/1078-0432.CCR-07-5165.

15.

Comparative screening of K-ras mutations in colorectal cancer and lung cancer patients using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing.

Zhang H, Zheng X, Ji T, Fu L, Bai D, Liao Y, Zhang H, Ding Y, Zheng L.

Cell Biochem Biophys. 2012 Apr;62(3):415-20. doi: 10.1007/s12013-011-9318-x.

PMID:
22048888
16.

Fast simultaneous detection of K-RAS mutations in colorectal cancer.

Chang YS, Yeh KT, Chang TJ, Chai C, Lu HC, Hsu NC, Chang JG.

BMC Cancer. 2009 Jun 11;9:179. doi: 10.1186/1471-2407-9-179.

17.

Mutations in K-ras and epidermal growth factor receptor expression in Korean patients with stages III and IV colorectal cancer.

Lee WS, Baek JH, Lee JN, Lee WK.

Int J Surg Pathol. 2011 Apr;19(2):145-51. doi: 10.1177/1066896911400411.

PMID:
21474505
18.

Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.

Soung YH, Lee JW, Kim SY, Seo SH, Park WS, Nam SW, Song SY, Han JH, Park CK, Lee JY, Yoo NJ, Lee SH.

Virchows Arch. 2005 May;446(5):483-8. Epub 2005 Apr 7.

PMID:
15815931
20.

Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.

Wang JY, Hsieh JS, Chang MY, Huang TJ, Chen FM, Cheng TL, Alexandersen K, Huang YS, Tzou WS, Lin SR.

World J Surg. 2004 Jul;28(7):721-6. Epub 2004 Jun 8.

PMID:
15185002

Supplemental Content

Support Center